Published in Cancer Weekly, June 24th, 2008
"Administration of N29 gamma chR-expressing T cells eliminated 3-day pulmonary micrometastases of MT901/ HER2 and MCA207/ HER2 but not parental tumor cells. A 5 to 8-fold increased dose of N29g T cells...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-06-24)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.